Why the study?
Numerous recent trials have clarified the role of the cardiac catheterization laboratory in managing resuscitated patients or those with ongoing cardiac arrest, warranting an updated contemporary approach.
Answers are grounded in this paper and cite their sources.
This AHA scientific statement provides updated guidance on the role of the cardiac catheterization laboratory in managing comatose adult patients with out-of-hospital cardiac arrest.
Out-of-hospital cardiac arrest is a leading cause of death, accounting for ≈50% of all cardiovascular deaths. The prognosis of such individuals is poor, with <10% surviving to hospital discharge. Survival with a favorable neurologic outcome is highest among individuals who present with a witnessed shockable rhythm, received bystander cardiopulmonary resuscitation, achieve return of spontaneous circulation within 15 minutes of arrest, and have evidence of ST-segment elevation on initial ECG after return of spontaneous circulation. The cardiac catheterization laboratory plays an important role in the coordinated Chain of Survival for patients with out-of-hospital cardiac arrest. The catheterization laboratory can be used to provide diagnostic, therapeutic, and resuscitative support after sudden cardiac arrest from many different cardiac causes, but it has a unique importance in the treatment of cardiac arrest resulting from underlying coronary artery disease. Over the past few years, numerous trials have clarified the role of the cardiac catheterization laboratory in the management of resuscitated patients or those with ongoing cardiac arrest. This scientific statement provides an update on the contemporary approach to managing resuscitated patients or those with ongoing cardiac arrest.
No takes yet. Share an insight, caveat, or question.
Tamis‐Holland et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: